To better understand the specific roles different immune cell types play, a multi-institutional team profiled the immune cell composition of multiple murine models and clinical datasets of triple negative breast cancers.
A team of researchers shows Food and Drug Administration (FDA)-approved compounds can stop cancer growth and can potentially lead to the discovery of drugs in a way that is quicker and less expensive than traditional drug development strategies.
Dr. Alastair Thompson is bringing his expertise Baylor as the new section chief of breast surgery in the Michael E. DeBakey Department of Surgery, Division of Surgical Oncology, and co-director of the Lester and Sue Smith Breast Center.
The National Cancer Institute has awarded $6.3 million dollars Baylor researchers to create new tools to help researchers to better understand the biological causes behind racial and ethnic health disparities in prostate and breast cancers.
Researchers have now discovered a mechanism by which cells can regulate switching between the two proteins, opening options for the development of novel therapeutic strategies to control cancer growth in the future.
An effort between a surgical oncologist and plastic surgeon can provide an opportunity for women diagnosed with breast cancer to not only have the lump removed, but also get a breast lift at the same time.
Oct. 13 has been declared Metastatic Breast Cancer Day by the Senate of the State of Texas. In honor of this proclamation, Baylor College of Medicine is launching a new program aimed at fighting the disease.